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Phosphate analogues in the dissection of mechanism
Heidi J Korhonen1,2, Louis P Conway1 and David RW Hodgson1
Phosphoryl group transfer is central to genetic replication,
cellular signalling and many metabolic processes.
Understanding the mechanisms of phosphorylation and
phosphate ester and anhydride cleavage is key to efforts
towards biotechnological and biomedical exploitation of
phosphate-handling enzymes. Analogues of phosphate esters
and anhydrides are indispensable tools, alongside protein
mutagenesis and computational methods, for the dissection of
phosphoryl transfer mechanisms. Hydrolysable and non-
hydrolysable phosphate analogues have provided insight into
the nature and sites of phosphoryl transfer processes. Kinetic
isotope effects and crystallography using transition state
analogues have painted more detailed pictures of transition
states and how enzymes work to stabilise them.
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Introduction
The mechanisms of phosphoryl transfer between nucleo-
philic centres have been investigated intensely over the
last half-century, with many generalisations of enzyme
catalytic strategies becoming evident [1]. Newly dis-
covered enzymes that foster phosphoryl transfer have
also regularly presented themselves, and offer fresh
ground for research alongside historically challenging
systems. The catalysis of phosphoryl transfer is particu-
larly intriguing given the manifest stability of diesters,
and monoester dianion systems. The delineation of the
strategies employed by enzymes to provide accelerations
of up to 1021-fold, gives enzymologists true insight into
some of Nature’s most efficient catalysts [2]. Visualisa-
tion and parameterisation of the highly dynamic inter-
actions between enzyme and substrate as they pass
through to products via heavily stabilised transition
states represents the long-standing challenge in this field.
This opinion brings together several recent examples of
phosphate ester analogues and their use in deciphering
the secrets of some of Nature’s most enticingly efficient
biocatalysts, in the context of ubiquitous phosphoryl
transfer processes (Scheme 1).
Approaches towards understanding transfers from phos-
phate monoesters, diesters and phosphoanhydride systems
will be included in this opinion. Both labile (reactive) and
stable (inhibitory) analogues are covered, where the former
usually, but not exclusively, tend to offer insight into the
dynamic processes that occur during bond making and
breaking between phosphorus and other nucleophilic
groups. In many cases, multi-pronged strategies are
adopted where parameterisations and inferences from
one mechanistic tool can be supported and enhanced by
others. The following three sections cover examples of
phosphate monester, diester and anhydride analogues.
Initially, each section focuses on examples where the
nature of the transition state and factors that stabilise it
can be extracted. Thereafter, examples that offer insight
into the site of bond scission though inhibition are covered.
The structures of the analogues covered within each sec-
tion are brought together in a table at the end of the section
alongside a summary of each analogue’s application.
Monoesters
Monoesters and their analogues have been studied exten-
sively over the last 50 or so years, however, their mech-
anisms of transfer, both under enzymatic catalysis and in
its absence, have remained controversial [1]. This sec-
tion includes examples of kinetic studies, using heavy
atom isotope effects, crystallographic studies that employ
agents to mimic parts of the phosphoryl transfer process,
and finally non-hydrolysable analogues that can be
employed as inhibitors and active site probes for a num-
ber of purposes that will be discussed in turn.
The mechanism of protein tyrosine
phosphatase 1B
A key illustration of the state of the art is the work of
Branda˜o et al. [3], where a combination of heavy-atom
isotope kinetic studies (Table 1, entry 1) complements
the use of vanadate-based transition state mimicry in
crystallographic studies (Table 1, entry 2) to reveal a
unified view of the dynamic interactions that occur be-
tween enzyme and transferring phosphoryl group during
both ‘ping’ and ‘pong’ steps of protein tyrosine phospha-
tase 1B. The key challenge in this area is the ability to
measure and interpret the small isotope effects that arise
from the use of heavy-atom systems.
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A phosphorane intermediate in the active site
of b-phosphoglucomutase?
A cautionary tale runs alongside crystallographic studies
that suggested the unusual occurrence and apparent
stability of a phosphorane during phosphate monoester
transfer in the active site of b-phosphoglucomutase [4].
The b-phosphoglucomutase enzyme mediates the trans-
fer of phosphate between hydroxyl groups within glucose,
via a ping-pong mechanism. The assertion of a phosphor-
ane intermediate, accessed through an addition-elimin-
ation mechanism sat contrary to the usual observation of
more dissociative pathways. Subsequent 19-F NMR stu-
dies showed that the postulated PO3
 group of the
phosphorane was, in fact, a MgF3
 system (Table 1, entry
3) [5], that is difficult to distinguish from the PO3
 group
using X-ray diffraction alone.
Similar 19-F NMR approaches with MgF3
, AlF3 and
AlF4
 transition state analogue systems have been used in
tandem with crystallographic and mutagenesis studies to
give insight into the balance between enzyme prefer-
ences for charge balancing versus isostery in several phos-
phoryl transferase enzymes [6–10].
Non-hydrolysable sugar-1-phosphate
analogues
Loranger et al. recently prepared L-rhamnose 1C-phos-
phonates (Table 1, entry 4) as potential inhibitors of
bacterial nucleotidylyltransferases, which are key to
the biosynthesis of viable cell walls [11]. The intention
was to explore methylene (X = Y = H), monofluoro-
methylene (X = F, Y = H) and difluoromethylene
(X = Y = F) systems as mimics of L-rhamnose 1-phos-
phate, however, synthetic difficulties prevented access
to the monofluoro system that could potentially offer the
best mimicry of the ionisation profile of the natural
phosphate [12]. Thiophosphonate analogues of sugar
1-phosphates have also recently been accessed synthet-
ically (Table 1, entry 5), where the methylene offers a
non-cleavable bridge, and sulfur offers modulated metal
ion-binding properties [13].
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Phosphodiesters
Phosphodiester models and mimics have been used
widely to understand the mechanisms of phosphodiester-
ases such as nucleases and ribozymes. This section dis-
cusses examples where one or more of the bridging or
non-bridging oxygen atoms associated with the phospho-
diester group has been exchanged for either sulfur or
fluorine. The resulting analogues are often reactive,
where their altered reactivity profiles are used to probe
the nature of catalysis in enzyme active sites and/or
binding to metal ions therein.
Phosphorothiolates in the quest for acid/base
catalysis by ribozymes
Some of the most poignant recent additions to the
mechanistic toolbox are the phosphorothiolates (Table
2, entry 1), where a bridging oxygen atom has been
replaced by sulfur. These systems have received signifi-
cant attention because synthetic advances have permitted
their use in oligonucleotides [14–16]. Phosphorothiolates
can also elucidate O-Mg2+ ion interactions through soft
metal ion rescue experiments. More significantly, where a
leaving group oxygen is replaced by sulfur, the enhanced
leaving group properties of thiolate anions accelerate
their departure, sometimes obviating the need for cata-
lysis, and potentially making previously kinetically silent
processes rate-determining. In this vein, phosphorothio-
late studies have illuminated HDV [17] and VS [18]
ribozyme systems alongside nucleobase substitutions to
provide unequivocal evidence in support of general acid/
base catalysis. Recent work in this area, primarily from the
Piccirilli laboratory, has been reviewed [19,20].
More detailed pictures of RNA hydrolysis
through the use of isotopes
More subtle substitution of phosphodiesters can be
effected through the use of isotopomeric compounds,
such as 18-O labelled species (Table 2, entry 2). Heavy
atom isotope effects are challenging to determine on a
practical level, however, isotopic substitutions represent
the least perturbing of all possible analogues. 50-18O and
20-18O isotopomeric analogues of the dinucleotide 50-
UpG-30 were synthesised and the base-promoted clea-
vage kinetics of these phosphodiester systems were
explored [21]. Through these studies, the transition
state for the 20-O-transphosphorylation process was
suggested to be late in nature, and solvent deuterium
isotope effect studies suggest the prior formation of the
20-alkoxide nucleophile rather than rate-determining gen-
eral base catalysis by hydroxide ion. An extension of this,
supplemented with computational studies, has been used
to revisit the mechanism of ribonuclease A [22].
Fluorophosphonates: diester or monoester?
Fluorophosphonates present the possibility of concerted,
diester-like transition states while offering the size and
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Table 1
A selection of phosphomonoester analogues and example applications
Entry Analogue structure Acronym/name Application Ref
1 pPNPP Determination of transition
state structure of phosphate
monoester transfer
[3]
2 Vanadate Transition state analogue for
phosphate monoester transfer
[3]
3 MgF3
, AlF3, AlF4
 – 19-F NMR and X-ray analyses
of active sites
[6–10]
4 Phosphonate/a-halophosphonate Non-scissile analogue of
rhamnose-1-phosphate
[11]
5 Thiophosphonate Non-scissile analogue of
sugar-1-phosphate
[13]
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hydrogen bonding characteristics of monoesters [23].
This mixed character was used to explore the promiscu-
ous proficiencies of phosphoryl transfer by alkaline phos-
phatase. Comparison of arylfluorophosphonates with
methyl aryl phosphate diesters (Table 2, entry 3, left)
as substrates for R166A alkaline phosphatase showed the
enzyme to have higher proficiency ([kcat/KM]/kuncat)
towards the diester, with both systems displaying signifi-
cantly reduced proficiencies compared to monoesters.
This was despite the fact that the fluorophosphonates
showed approximately 1000-fold higher reactivities
towards hydroxide ion. This differentiation between
transition states in the enzyme active site contrasts with
other systems that have shown greater promiscuity
[24,25], despite the deliberately small perturbation of
the fluorophosphonate substrates away from native
monoesters. A fluoronucleotide system (Table 2, entry
3, right) was employed alongside a number of other
nucleoside-50-phosphate analogues to demonstrate that
Fhit proteins recognise and hydrolyse substrates beyond
the dinucleoside triphosphates that they normally act
upon [26].
Phosphoanyhydrides
Phosphoanhydrides such as (deoxy)ribonucleoside tri-
phosphates and sugar nucleotides are central to the
actions of polymerases, kinases and glycosyl transferases
inter alia. Phosphoanhydride analogues where bonds or
atoms that are involved in enzyme-catalysed transfer have
been replaced, provide substrates and inhibitors that offer
mechanistic insight, however, their synthesis and iso-
lation is particularly laborious.
Below, three specific examples of the exploitation of
phosphoanhydride analogues in mechanistic studies are
presented. These include non-hydrolysable systems that
are key to X-ray crystallographic studies, and differen-
tially activated/deactivated mimics for kinetic studies
that can complement protein mutation studies to delin-
eate the roles of key active site residues. Uncatalysed
solution studies of substrates and analogues, in the
absence of enzyme, are also essential for benchmarking
catalytic acceleration factors, and to gain mechanistic
insight without the complicating factors that proteins
bring [27–29].
The mechanism of RNA ligase RtcB
RtcB is a non-canonical RNA ligase that joins a 30-phos-
phate with a 50-hydroxyl using GTP and Mn(II) ions.
Desai and Raines used GTP analogues (GTPaS, GppCP,
GppNHp, GTPgS and GPcPP, Table 3, entry 1) to
determine the site of triphosphate scission during this
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Table 2
A selection of phosphodiester analogues and example applications
Entry Analogue structure Acronym/name Application Ref
1
 
Phosphorothiolate Modulation of leaving group
pKa/metal ion interaction
probe
[14–16,17,18,19]
2
 
18-O isotopomers Probing transition
state structure
[21,22]
3
 
Fluorophosphonate Isosteric monoester analogue
with altered perturbed TS for
phosphoryl transfer
[23,26]
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Table 3
A selection of phosphoanhydride analogues and example applications
Entry Analogue structure Acronym/name Application Ref
1
 
GTPaS; X = S, Y = Z = U = O
GpCpp; Y = CH2, X = Z = U = O
GppNHp; Z = NH, X = Y = U = O
GppCp; Z = CH2, X = Y = U = O
GTPgS; U = S, X = Y = Z = O
Studying the mechanism of
RNA ligase RtcB
[30,31]
2 a,b-Difluoromethylene-triphosphate Evaluating the structure and
mechanism of polb
[33]
3 X = CH2, CHF, CHCl, CHBr, CCl2,
CBr2, CCl2, CFCl or CF2
Studying the mechanism
of polb
[34,35,54]
4 Variously:
R1 = Me or Bn
R2, R3 = H or Me
X = O or S
Y1, Y2 = O, NH, CH2
N = H or 50-guanosine
n = 1 or 2
Studying mRNA cap structure
interactions and hydrolysis
[43]
5 boranophosphate
20-OMe ATP(aB); X = OH, Y = OCH3
30-dATP(aB); X = H, Y = OH
Inhibitors to hepatitis C virus. [44]
6 Boranophosphate Efficient and selective agonist to
P2Y6-receptor.
[45]
7
 
APCPP(aS) Potential in the development
of therapeutics against
Alzheimer’s disease
[48]
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Table 3 (Continued )
Entry Analogue structure Acronym/name Application Ref
8
 
X = Me, or H Diastreomerically pure
precursor for new analogues.
[50]
9
 
ApCH2OpOCH2pA Inhibitor for Ap4A hydrolase [51]
10
 
UDP-C1-phosphonate-sugar Revealing UDP-apiose/UDP-xylose
synthase mechanism.
[52]
11 a,b-b,g-Bisdifluoromethylene-triphosphate Nonhydrolysable nucleotide
analogue
[53]
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process [30]. Their mechanism proposes the formation
of a 20,30-cyclic phosphate that is opened by nucleophilic
attack of the 50-hydroxyl of the ligating strand. The a,b-
methylene analogue GpCpp proved unable to support the
healing action of RtcB, suggesting that a,b-fission of GTP
is critical. Further insight through crystallography using
GTPaS and Mn(II) ions suggested the importance of
hydrogen bonding networks and the second Mn(II) ion in
orientating the triphosphate in the active site in an
appropriate conformation for in-line attack by the active
site His nucleophile [31]. The GMP-His intermediate is
then attacked by the 30-phosphate of the 30-ligating strand
to form a activated guanylate, and the 20-OH then attacks
to form the 20,30-cyclic phosphate in readiness for ligation.
The mechanism and stereoselectivity of DNA
polymerase b
The use of dNTP analogues in mechanistic studies was
reviewed in 2010 by McKenna et al. [32], however, this
team has recently augmented the dNTP analogue reper-
toire with a range of a,b-halomethylene-triphosphate
systems (Table 3, entry 2). These systems were prepared
chemoenzymatically (e.g. a,b-CF2-dCTP) or using the
morpholidate method (e.g. a,b-CF2–dTTP) to study
stereoelectronic effects within the triphosphate group
through variation of the halo substituent and subsequent
crystallographic studies in the presence of these non-
hydrolysable analogues [33]. In earlier complementary
works, McKenna and colleagues employed b,g-bridge
analogues that allowed perturbation of the pyrophosphate
leaving group pKa [34
,35]. Fortunately, the b,g-halo-
methylene-GTP analogues were substrates, and their
kinetic activities were correlated using linear free energy
relationships (LFER). Human DNA polb incorporated
b,g-halomethylene-GTP against both cognate C and non-
cognate T template residues, with the chemical step
being rate-limiting in both cases. Unsurprisingly, cognate
incorporation was markedly faster than non-cognate, how-
ever, individually, the two sets of kinetic data correlated
under LFER analyses. Reduced activities were measured
for the bulkier dihalogen substrates where the template
base was also influential in the magnitude of diminished
activity. The detection of even lower catalytic activity for
mispairs serves as a potential tool to explore the structural
distinctions between transition states derived from cog-
nate or non-cognate base incorporations.
The use of substituted methylene bridges, -CXY- poten-
tially introduces an additional stereogenic centre into b,g-
dGTP analogues (Table 3, entry 3). Crystallisation of
DNA polb in the presence of disasterometric mixtures of
each of b,g-CHF, CMeF and CClF dGTP analogues led
to selective active site occupancy by the diastereomers
that allowed the formation of CX-F-Arg183 hydrogen
bonds [36]. Diastereomerically pure b,g-CHF-dGTP
and b,g-CHCl-dGTP were prepared and the R and S-
configurational isomers were assessed kinetically [37]. R-
diastereomers proved more proficient substrates than S,
with the R-b,g-CHF-dGTP being most effective,
confirming the advantageous effect of the CX-F-
Arg183 interaction [38].
mRNA cap analogues
Synthetic methodologies for the preparation of mRNA
cap analogues have been developed to study biotechno-
logically and medicinally significant cap-dependent pro-
cesses (Table 3, entry 4) [39–42]. The binding and
hydrolysis of 50-cap mimics by the cap scavenger from
Caenorhabditis elegans (CeDcpS) were explored using a
collection of methylenephosphonate, imidodiphosphate
and phosphorothioate cap analogues, revealing regiose-
lective b,g-cleavage [43].
Other phosphoanhydride analogues
Recent examples include stereopure a-P-boranopho-
sphate-ATPs that have shown anti-hepatitis C activity
(Table 3, entry 5) [44] and selective agonism against the
P2Y6 receptor (Table 3, entry 6) [45]. Further elaboration
of the boranophosphate based triphosphate to include a
b,g-dichloromethylene group provided a promising P2Y11
receptor antagonist [46]. Systems combining phosphor-
othioate and bridging oxygen-substitutions (Table 3,
entry 7) have demonstrated potential as therapeutics
against Alzheimer’s disease owing to their metal ion
chelation properties [47,48]. The use of sulfur-based
analogues in the determination of mechanism has been
reviewed recently [49]. Recent synthetic advances have
also given (easier) access to: azido-phosphonate dNTPs,
where bridging O-atoms have been replaced by –CHN3–
groups (Table 3, entry 8), and these analogues can be
isolated as separate diastereomers [50]; and oxymethyl
analogues (CH2 insertion between O and P within anhy-
dride linkages) for following ApnA and NpnN degradation
and metabolism (Table 3, entry 9) [51]. Phosphonate
NDP-sugar analogues, where the C1-oxygen of the gly-
cosyl group has been replaced by methylene, have given
insight into the mechanism of UDP-apiose/UDP-xylose
synthase (Table 3,entry 10) [52], and bis-a,b-b,g-CF2-
NTPs offer sterically undemanding mimics that do not
hydrolyse while maintaining comparable polarity proper-
ties to their natural NTP progenitors (Table 3,entry 11)
[53].
Conclusions and future
Multi-faceted approaches combining several experi-
mental techniques and/or computational methods are
currently giving some of the clearest pictures of phos-
phoryl transfer strategies. Most of these approaches
have, in principle, been available for some time, how-
ever, experimental difficulties have precluded their
exploitation. Synthesis of analogues remains a substan-
tial obstacle, with many ‘obvious’ analogues only
becoming accessible through painstaking development
of challenging routes. This is particularly true of the
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phosphoanhydride systems. Fortunately, several groups
are working towards more convenient methodologies for
the preparation of phosphoesters, anhydrides and their
analogues, and details of these efforts can be accessed else-
where [55,56,57,58,59,60,61,62,63,64,65,66,67,68,69].
Heavy isotope kinetic studies have proven extremely enligh-
tening, however, the measurement of these extremely small
effects (even in best case scenarios) remains the preserve of a
few specialist groups. Combinations of experimental
approaches with computational methods are also allowing
more rigorous, quantitative assessment of observed kinetic
data, where interpretations of kinetic results can often be
complex. In summary, synthetic methodology, in tandem
with kinetic measurements and computational dissection
are providing enzymologists with an enhanced toolbox for
the determination of phosphoryl transfer mechanisms.
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